{"version":"1.0","type":"link","title":"Cadonilimab (PD-1/CTLA-4 bispecific antibody) combination therapy for driver gene-negative advanced NSCLC: a single-center retrospective real-world study.","author_name":"Zeng L 외","author_url":"https://prs-insight.online/author/Zeng%20L","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/97111","thumbnail_width":1200,"thumbnail_height":630}